Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia.
Por:
Sorigue M, Magnano L, Miljkovic MD, Nieto-Moragas J, Santos-Gomez M, Villamor N, Junca J and Morales-Indiano C
Publicada:
1 sep 2020
Ahead of Print:
1 nov 2019
Resumen:
The role of CD200 in the differential diagnosis of chronic lymphocytic leukemia (CLL) and classical mantle cell lymphoma (MCL) is well established. Its role in the differential diagnosis of CLL and other lymphoproliferative disorders (LPD) is less clear, in particular its positive predictive value (PPV).
Filiaciones:
:
Hematology Laboratory, ICO-Hospital Germans Trias i Pujol. IJC, Universitat Autònoma de Barcelona, Badalona, Spain
Magnano L:
Hematopathology Unit, Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain
Miljkovic MD:
Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland
Nieto-Moragas J:
Clinical Laboratory, Hospital Dr Josep Trueta, Girona, Spain
Santos-Gomez M:
Hematology Laboratory, ICO-Hospital Germans Trias i Pujol. IJC, Universitat Autònoma de Barcelona, Badalona, Spain
Villamor N:
Hematopathology Unit, Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain
:
Hematology Laboratory, ICO-Hospital Germans Trias i Pujol. IJC, Universitat Autònoma de Barcelona, Badalona, Spain
:
Clinical Laboratory ICS-Metropolitana Nord, Core-hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain
|